Clinical Trials Browser

Phase 1/2 × INDUSTRY × Nerve Growth Factor × Clear all

NCT07008703 2025-06-06

Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain

Phase 1/2 Recruiting

Cancer Pain